Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital

Infection Control and Hospital Epidemiology

Volumn 30, Issue 11, 2009, Pages 1031-1035

  Munoz Price, L Silvia ^a   Hota, Bala ^b   Stemer, Alexander ^a   Weinstein, Robert A ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETASEPT; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; UNCLASSIFIED DRUG; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; BATH; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DRUG WITHDRAWAL; EVALUATION; HOSPITAL; HUMAN; INCIDENCE; INFECTION PREVENTION; LONG TERM ACUTE CARE HOSPITAL; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRURITUS; SKIN REDNESS; UNITED STATES; VENTILATOR ASSOCIATED PNEUMONIA; BACTEREMIA; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; INFECTION CONTROL; LONG TERM CARE; METHODOLOGY; MICROBIOLOGY;

ANTI-INFECTIVE AGENTS, LOCAL; BACTEREMIA; BATHS; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CHLORHEXIDINE; CROSS INFECTION; HOSPITALS, SPECIAL; HUMANS; INFECTION CONTROL; LONG-TERM CARE;

EID: 71949099817     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/644751     Document Type: Article

References (19)

1. Klevens RM, Edwards JR, Gaynes RP. The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis 2008; 47:927-930.
2. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167:2073-2079.
3. Mimoz O, Villeminey S, Ragot S, et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med 2007; 167:2066-2072.
4. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732.
5. Dematte D'Amico JE, Donnelly HK, Mutlu GM, Feinglass J, Jovanovic BD, Ndukwu IM. Risk assessment for inpatient survival in the long-term acute care setting after prolonged critical illness. Chest 2003; 124:1039-1045.
6. Scheinhorn DJ, Chao DC, Hassenpflug MS, Gracey DR. Post-ICU weaning from mechanical ventilation: the role of long-term facilities. Chest 2001; 120(6 Suppl):482S-484S.
7. Lusk R, O'Bryan L. Evaluation of critically ill patients for transfer to long-term acute-care facilities. Lippincotts Case Manag 2002; 7:24-26.
8. Seneff MG, Wagner D, Thompson D, Honeycutt C, Silver MR. The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoing prolonged mechanical ventilation. Crit Care Med 2000; 28:342-350.
9. Munoz-Price, L. S. Long-term acute care hospitals. Clin Infect Dis 2009; 49: 438-443.
10. Wolfenden LL, Anderson G, Veledar E, Srinivasan A. Catheter-associated bloodstream infections in 2 long-term acute care hospitals. Infect Control Hosp Epidemiol 2007; 28:105-106.
11. Yang CM, Reinke W. Feasibility and validity of International Classification of Diseases based case mix indices. BMC Health Serv Res 2006; 6:125.
12. Munoz-Price LS, Hota B, Nimon N, et al. Effect of a ventilator-associated pneumonia (VAP) infection control bundle for the prevention of VAP in a long-term care acute hospital (LTACH). In: Program and abstracts of the 18th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Orlando). Arlington, VA: Society for Healthcare Epidemiology of America; 2008:134. Abstract 379.
13. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in longterm acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006; 27:920-925.
14. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
15. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007; 45:901-907.
16. Vernon MO, Hayden MK, Trick WE, Hayes RA, Blom DW, Weinstein RA; Chicago Antimicrobial Resistance Project (CARP). Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006; 166:306-312.
17. Romero-Gómez MP, Quiles-Melero MI, Peña García P, et al. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol 2008; 29:377-378.
18. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S22-S30.
19. Rosenthal MB. Nonpayment for performance? Medicare's new reimbursement rule. N Engl J Med 2007; 357:1573-1575.